We've helped cure
more than a
million patients.

Watch what's next.

Great Chemistry Cures

At Enanta, we are committed to creating important, novel medicines by pursuing bold ideas, employing rigorous research, and striving for scientific excellence in everything we do. We are fortunate to have some of the best and brightest minds across pharma and biotech working at Enanta. We are passionate about science and dedicated to discovering and developing highly differentiated therapeutics through innovative chemistry to treat diseases in areas of high unmet need. These efforts have resulted in developing drugs for combination regimens that have cured more than one million people with chronic hepatitis C virus infection. It’s incredibly rewarding for our scientific expertise to have such an impact on patients’ lives, and this drives us to do it again in other disease areas.

Pipeline »

great-chemistry-shapes-lg-blue

Virology

great-chemistry-shapes-lg-ltblue

Immunology

About Us

Enanta’s heritage is steeped in scientific expertise and a track record of effective innovation. Without either, we wouldn’t be where we are today. We are dedicated to applying these capabilities and experience each day in hopes of improving patients’ lives. We’ve done it before, and we’re determined to do it again.

About »

December 9, 2024

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)

Read More »

December 6, 2024

Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)

Read More »

November 25, 2024

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024

Read More »